Posts Tagged ‘Càncer de pulmó’

Wednesday January 18th, 2017

A diagnostic test for lung cancer detects genetic alterations which may remain hidden when conventional techniques are used

A study led by researchers from Hospital Clínic-IDIBAPS, in collaboration with Dexeus University Hospital, shows the effectiveness of a new genetic test for molecular diagnosis in lung cancer. This is the first time that a test for this type of tumor is implemented in clinical practice. It consists of analyzing three genes with an innovative genomic technology that allows detecting multiple alterations which may not be identified when conventional diagnostic techniques are used. If these genetic alterations are detected, the patient can be treated with an oral drug that has minimal toxicity and a very high clinical benefit. The study has been coordinated by Dr. Noemí Reguart, an oncologist at the Hospital Clínic-IDIBAPS, and Dr. Aleix Prat, head of the Clinical Oncology Department and of the IDIBAPS research team on Translational Genomics and directed therapies in solid tumors.

Read the rest of this entry »

Comments Closed
Tuesday July 19th, 2016

Hospital Clínic makes a commitment to the molecular diagnostic of solid tumors in clinical practice

Hospital Clínic de Barcelona goes one step forward in the molecular diagnosis of solid tumors with a single test that detects multiple mutations within 22 genes in patients with advanced lung cancer, melanoma and colorectal cancer. The implementation of this genetic test based on massive parallel sequencing technologies allows shortening the time of diagnosis and personalizing the treatment for each patient. With this test, the Medical Oncology department at Hospital Clínic, together with the Biomedical Diagnostic Center (CDB), positions at the forefront of the clinical application of this diagnostic tool in the Spanish public health system, because of the technology used and the number of genes and tumors analyzed.

Read the rest of this entry »

Comments Closed
Wednesday October 28th, 2015

University of Barcelona and Hospital Clínic collaborate to improve the efficacy of advanced lung cancer treatment

To advance in the fight against lung cancer,  University of Barcelona (UB) and  Hospital Clínic of Barcelona collaborate with Boehringer Ingelheim to look for new ways of nintedanib efficiency, an anti-angiogenic drug for the treatment of this disease. Lung cancer is the leading cause of cancer death worldwide and November is the international month of this disease.

Read the rest of this entry »

Comments Closed